The Ensign Group Stock News

In a report released today, Michael Wiederhorn from Oppenheimer maintained a Buy rating on Humana (HUM), with a price target of $400.00. The company's

In a report released today, Michael Wiederhorn from Oppenheimer maintained a Buy rating on Humana (HUM – Research Report), with

Brokerages predict that The Ensign Group, Inc. (NASDAQ:ENSG) will announce $0.62 earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Two analysts have made estima

In a report released yesterday, Michael Wiederhorn from Oppenheimer maintained a Buy rating on Community Health (CYH), with a price target of $8.00. The

In a report released yesterday, Michael Wiederhorn from Oppenheimer maintained a Buy rating on Community Health ( CYH – Research Report ), with a price target of $8.00 . The company’s shares close

Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on Chemed (CHE) yesterday and set a price target of $535.00. The company's shares closed

Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on Chemed (CHE – Research Report) yesterday and set a price target

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Centene (CNC) and Moderna (MRNA) with bullish sentiments.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Centene ( CNC – Research Report ) and Moderna ( MRNA – Research Report ) with bullish sentiments. C

The "Nursing Care Market in US - Industry Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The US Nursing Care Market is expected to grow at a CAGR of o

Wall Street brokerages forecast that The Ensign Group, Inc. (NASDAQ:ENSG) will report $578.59 million in sales for the current quarter, Zacks reports. Two analysts have provided estimates for The Ensi

The "Nursing Care Market in US - Industry Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.

Ensign Group (ENSG) could produce exceptional returns because of its solid growth attributes.

Ensign Group (ENSG) could produce exceptional returns because of its solid growth attributes.

Ensign Group (ENSG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.